Assistant Professor of Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Beth A. Overmoyer, MD
|
|
Give Review
Beth Overmoyer is an expert in the field of Hematology. She researched medicine at Case Western Reserve University School of Medicine. She over the years received 3 awards: "America's Top Doctors for Cancer", "Fellow (FACP)" and "Super Doctor". Beth A. Overmoyer, MD has written publications. She has 51 publications published with PubMed. The lastest publication is: 'The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer.' Beth Overmoyer accepts Medicare payments and is registered with Medicare.gov.
Publications
- Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
- Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast Cancer.
- Prospective clinical experience with research biopsies in breast Cancer patients.
- Microinvasive Breast Cancer: ER, PR, and HER-2/neu Status and Clinical Outcomes after Breast-Conserving Therapy or Mastectomy.
- Case records of the Massachusetts General Hospital. Case 17-2011. A 49-year-old woman with a mass in the Breast and overlying skin changes.
- Inflammatory breast Cancer: novel preoperative therapies.
- Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast Cancer.
- The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast Cancer.
- What Radiologists Need to Know about Diagnosis and Treatment of Inflammatory Breast Cancer: A Multidisciplinary Approach.
- Pegylated liposomal doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast Cancer.
- Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases...
- A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast Cancer.
- Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced...
- Chemotherapy in the management of breast Cancer.
- Uniformity of Liver density and nonheme (storage) iron distribution.
- High-dose chemotherapy with autologous stem cell support for breast Cancer.
- Chemotherapeutic palliative approaches in the treatment of breast Cancer.
- Ifosfamide in the treatment of breast Cancer.
- High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast Cancer in patients with 4-9 involved axillary lymph nodes.
- The breast Cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast Cancer.
- A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic Carcinoma of the head and neck.
- Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced Cancer.
- Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast Cancer: multicenter phase II trial with clinical outcomes, analysis of seru...
- Combination chemotherapy for metastatic breast Cancer: reaching for the cure.
- A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients ...
- Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast Cancer refractory to paclitaxel.
- A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast Cancer: impact on angiogenic biomarkers.
- Options for the treatment of patients with taxane-refractory metastatic breast Cancer.
- Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast Cancer.
- Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
- Inflammatory breast Cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
- Rebeccamycin analog for refractory breast Cancer: a randomized phase II trial of dosing schedules.
- Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
- Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast Cancer.
- Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast Cancer.
- Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast Cancer patients after autologous peripheral blood prog...
- Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
- Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
- Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.
- A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.
- Progressive disease after ABMT for Hodgkin''s disease.
- Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast Cancer receiving dose-...
- Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
- G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 micrograms/kg/day.
- An analysis of prognostic features in infiltrating lobular carcinoma of the Breast.
- Murine leukemia virus infection in immunocompetent adult mice.
- The influence of young age on outcome in early stage breast Cancer.
- The effects of gonadotropins on metabolism of isolated rat granulosa cells.
- The significance of signet ring cells in infiltrating lobular carcinoma of the Breast.
- Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
Schools
Case Western Reserve University School of Medicine
Hospital University Pa
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- Fellow (FACP)
- Super Doctor
Education
-
University of Pennsylvania Health System -
Case Western Reserve University School of Medicine
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1801827209 | |
| NPPES Provider LastName | OVERMOYER | |
| NPPES Provider FirstName | BETH | |
| NPPES Provider ZIPCode | 021156013 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 299.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801827209 |
| Last Name Of The Provider | OVERMOYER |
| First Name Of The Provider | BETH |
| View All |
Similar Doctors
|
|
Dr. David B. Chou, MD |
|
|
Dr. Priscilla K. Brastianos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michal Bar-Natan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcus O. Butler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul E. Goss, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kirstine Y. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy Warner, MD |
|
|
Dr. Allison Ackerman, MD |
|
|
Dr. David M. Jackman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dejan Juric, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy S. Abramson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriela Motyckova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer A. Chan, MD |
|
|
Dr. Rita A. Blanchard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank C. Passero Jr., MD |